Back
ESC Professional Premium Access

Prevalence of illicit drugs use and association with in-hospital major adverse events in patients hospitalised for acute cardiac events: the ADDICT-ICCU Trial

Session: Acute cardiac care and COVID
Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care
Speaker: Doctor T. Pezel (Paris, FR)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Theo Pezel

Lariboisiere APHP Site of Saint Louis University Hospital, Paris (France)
13 presentations
10 followers

7 more presentations in this session

Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction.

Speaker: Professor Z. Motovska (Prague, CZ) Doctor O. Hlinomaz (Brno, CZ)

Access
Abstract
Slides
Like
Thumbnail

Impact of early readmission to the cardiac ICUon in-hospital mortality and hospital length of stay in 30,942 cardiac patients.

Speaker: Doctor T. Thevathasan (Berlin, DE)

Access
Abstract
Slides
Like
Thumbnail

Variables associated with bleeding and thrombotic outcomes among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomised clinical trial

Speaker: Doctor P. Barros E Silva (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Atrial fibrillation in COVID-19 patients admitted to an intensive care unit: prevalence and prognosis

Speaker: Doctor V. Lopes (Coimbra, PT)

Access
Abstract
Slides
Like
Thumbnail

Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis

Speaker: Doctor P. Jirak (Salzburg, AT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Acute cardiac care and COVID

Speakers: Doctor T. Pezel, Professor Z. Motovska, Doctor O. Hlinomaz, Doctor T. Thevathasan, Doctor P. Barros E Silva...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources